Completed PHASE3 INTERVENTIONAL NCT00003364

Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer

A Randomised Study of Timing of Thoracic Irradiation in Small Cell Lung Cancer (Study 8)

Sponsor: London Lung Cancer Group

Interventions cisplatin cyclophosphamide doxorubicin hydrochloride etoposide radiation therapy vincristine sulfate

Updated 6 times since 2017 Last updated: Dec 18, 2013 Started: Jan 31, 1993 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Lung Cancer, this trial is completed. The trial is conducted by London Lung Cancer Group and has accumulated 6 data snapshots since 1993. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London Lung Cancer Group

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ascot, United Kingdom , Brighton, United Kingdom , Cambridge, United Kingdom , Chelmsford, Essex, United Kingdom , Colchester, United Kingdom , Hampstead, London, United Kingdom , Leeds, United Kingdom , London, United Kingdom , Northwood, United Kingdom , Peterborough, United Kingdom and 1 more location